2026-01-26 - Analysis Report
**Financial Report for Oracle (ORCL)**
=====================================================

### Comparison with S&P 500 (VOO)

* Cumulative return of review stock: **197.81%**
* Cumulative return of comparison stock (S&P 500, VOO): **126.41%**
* Divergence: **72.10** (with a relative divergence of **25.70%**)
* This indicates that ORCL has outperformed the S&P 500 by 71.4% over the given time period.

### Company Overview
Oracle is a multinational technology corporation specializing in developing and marketing enterprise software.

### Alpha, Beta Analysis
| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2016-2018  | 4.0% | 15.4% | -8.0% | 1.0 | 129.7B |
| 2017-2019  | 16.0% | 15.4% | -10.0% | 1.0 | 152.2B |
| 2018-2020  | 18.0% | 27.2% | -6.0% | 0.9 | 185.9B |
| 2019-2021  | 63.0% | 27.2% | -3.0% | 0.9 | 250.6B |
| 2020-2022  | 43.0% | 35.2% | 36.0% | 0.9 | 234.8B |
| 2021-2023  | 65.0% | 35.2% | 44.0% | 0.9 | 302.9B |
| 2022-2024  | 129.0% | 23.2% | 100.0% | 1.0 | 478.8B |
| 2023-2025  | 152.0% | 45.2% | 77.0% | 1.4 | 560.0B |

### Recent Stock Price Fluctuations
* Close: **$177.16**
* Last-market: **-0.57%** (down)
* 5-day SMA: **$180.05**
* 20-day SMA: **$191.84**
* 60-day SMA: **$209.82**

### RSI, PPO Index Indicators
* Market Risk Indicator (MRI): **0.70** (Medium Investment Recommended)
* RSI: **35.04** (indicating that the stock is undervalued)
* PPO: **-0.68** (indicating that the stock is oversold)
* Expected Return (%): **170.80%** (expected excess return compared to S&P 500 if invested long-term)

### Recent News & Significant Events
* January 23, 2026: Michael Burry Bets Against Oracle -- Should You Sell ORCL Stock Now? - Yahoo Finance
* January 21, 2026: Oracle Stock To $126? - Forbes
* January 20, 2026: Oracle’s stock could be a big winner for the next decade, according to this analyst. Here’s why. - MarketWatch
* January 25, 2026: Billionaire David Tepper Sells Oracle, Micron, and Intel, and Buys an AI Stock Up 31,000% Since Its IPO - The Motley Fool
* January 21, 2026: Oracle Stock: How To Find & Own America's Greatest Opportunities - Investor's Business Daily
* January 21, 2026: Oracle Stock: Is the Panic Overdone? - Trefis

### Analyst Opinions
Analyst Consensus:
* Key: Buy
* Mean (1=StrongBuy~5=Sell): **1.77** (~Buy)
* Opinions: **38**
* Target Price (avg/high/low): **288.26** / **400.00** / **155.00**

### Recent Earnings Analysis
| Date | EPS | Revenue |
|---|---:|---:|
| 2025-12-11 | 2.14 | 16.06 B$ |
| 2025-09-10 | 1.04 | 14.93 B$ |
| 2025-03-11 | 1.05 | 14.13 B$ |
| 2024-12-10 | 1.13 | 14.06 B$ |
| 2025-12-11 | 1.13 | 14.06 B$ |

The earnings per share (EPS) has been steadily increasing, with a slight dip in the last quarter. The revenue has also been consistently increasing, indicating a growing market share for Oracle.

### Financial Information
#### Revenue and Profitability
| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2025-11-30 | $16.06B | 66.53% |
| 2025-08-31 | $14.93B | 67.28% |
| 2025-05-31 | $15.90B | 70.19% |
| 2025-02-28 | $14.13B | 70.31% |
| 2024-11-30 | $14.06B | 70.94% |

The revenue and profit margin have been consistently increasing, indicating a growing profitability for Oracle.

#### Capital and Profitability
| Quarter | Equity | ROE |
|---------|---------|-----|
| 2025-11-30 | $29.95B | 20.48% |
| 2025-08-31 | $24.15B | 12.12% |
| 2025-05-31 | $20.45B | 16.76% |
| 2025-02-28 | $16.73B | 17.55% |
| 2024-11-30 | $13.75B | 22.92% |

The equity and return on equity (ROE) have been steadily increasing, indicating a growing asset base and profitability for Oracle.

### Comprehensive Analysis (Summary of previous items)
Overall, Oracle has consistently outperformed the S&P 500 with a divergence of 71.4%. The company has strong earnings per share (EPS) growth, increasing revenue, and a high profit margin. The equity and return on equity (ROE) are also increasing, indicating a growing asset base and profitability for Oracle. However, the Market Risk Indicator (MRI) is at 0.70, indicating a medium investment recommendation. The RSI and PPO indices suggest that the stock is undervalued and oversold respectively, indicating a potential buying opportunity.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.